Drag a card by its title · ⚙ to size, swap or remove

The company

Zentalis Pharmaceuticals, Inc.

ZNTL · Nasdaq

Health CareBiotechnologyNot moving yet

ZNTL stood above a rising 150-day average in 34 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 43.5% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 6
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $45.8M
Insider sales, 12 months: $10.2M
Officials’ trades on record: 0
Institutions holding: 112 (+16)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 34 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4

Sale orders, 12 months10

Buyers · sellers2 · 4

Who	Did	Shares	Traded
Walters Group10% owner	bought	4,335,000at $3.50	14 Aug 2026filed 19 Aug 2026
Vincent VultaggioPAO and PFO	sold	6,894at $2.42	10 Feb 2026filed 10 Feb 2026
Julia Marie EastlandCEO & President	sold	889at $2.39	9 Feb 2026filed 10 Feb 2026
Ingmar BrunsChief Medical Officer	sold	335at $2.39	9 Feb 2026filed 10 Feb 2026
Vincent VultaggioPAO and PFO	sold	3,379at $2.39	9 Feb 2026filed 10 Feb 2026
Julia Marie EastlandCEO & President	sold	7,866at $2.43	6 Feb 2026filed 10 Feb 2026
Ingmar BrunsChief Medical Officer	sold	2,962at $2.43	6 Feb 2026filed 10 Feb 2026
Vincent VultaggioPAO and PFO	sold	29,951at $2.43	6 Feb 2026filed 10 Feb 2026
Vincent VultaggioPAO and PFO	sold	556at $2.52	3 Feb 2026filed 4 Feb 2026
Vincent VultaggioPAO and PFO	sold	2,540at $2.55	2 Feb 2026filed 4 Feb 2026
Walters Group10% owner	bought	6,459,973at $1.20	31 Dec 2025filed 8 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders112+16 on the quarter

New · exited35 · 21

Reported value$214.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
5AM Venture Management, LLCunchanged · filed 14 Aug 2026	3,947,913$19.1M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	3,753,525$18.2M	+2,483,688+195.6%
Squadron Capital Management LLCadded · filed 14 Aug 2026	3,700,000$17.9M	+69,000+1.9%
TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026	3,024,936$14.7M	+68,410+2.3%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	2,835,669$13.8M	+524,962+22.7%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026	2,298,403$11.1M	+566,320+32.7%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026	1,609,078$7.8M	-329,067−17.0%
Opaleye Management Inc.unchanged · filed 14 Aug 2026	1,412,656$6.9M	00.0%
ORBIMED ADVISORS LLCnew · filed 14 Aug 2026	1,390,576$6.7M	+1,390,576
Decheng Capital LLCunchanged · filed 14 Aug 2026	1,323,327$6.4M	00.0%